Ryan McDonald

Ryan McDonald, Associate Editorial Director for CURE®, has been with the team since February 2020 and has previously covered medical news across several specialties prior to joining MJH Life Sciences. He is a graduate of Temple University, where he studied journalism and minored in political science and history. He considers himself a craft beer snob and would like to open a brewery in the future. During his spare time, he can be found rooting for all major Philadelphia sports teams. Follow Ryan on Twitter @RMcDonald11 or email him at rmcdonald@curetoday.com.

Articles

Combination Therapy Shows Overall Survival Benefit in Advanced Breast Cancer

Ryan McDonald

March 4th 2020

The combination of Kisqali and Faslodex shows improved overall survival in patients with hormone-receptor-positive, HER2-negative advanced breast cancer.

$Novel Combination May Address Unmet Need in Relapsed or Refractory Acute Myeloid Leukemia$

Novel Combination May Address Unmet Need in Relapsed or Refractory Acute Myeloid Leukemia

Ryan McDonald

March 2nd 2020

Treatment options for patients with acute myeloid leukemia are limited, especially for older patients, but a new trial looking at novel therapy combinations could change the treatment landscape.

Skin Cancer Prevalence Higher in Men Who Identify as Gay, Bisexual

Ryan McDonald

February 26th 2020

Men who identify as gay or bisexual report having more skin cancers than those who identify as heterosexual. More frequent use of indoor tanning could be a cause, but researchers want to find out for sure.

Keytruda Plus Chemoradiation Shows Promise in Locally Advanced NSCLC

Ryan McDonald

February 25th 2020

The combination of Keytruda plus chemoradiotherapy induced a ‘promising’ 12-month progression-free survival rate in patients with locally advanced non-small cell lung cancer.

...

13 14 15 16 17